Long-Term Complications of Kidney Transplantation
View More View Less
  • 1 Texas A&M University, School of Engineering Medicine, Houston, TX
  • | 2 Division of Renal Disease and Hypertension, Houston Methodist Hospital, Houston, Texas
  • | 3 Division of Transplant Nephrology, University of Texas at Houston Health Science Center, Houston, Texas
  • | 4 Transplant Center, Memorial Hermann Hospital, Houston, Texas
  • 1

    Agrawal A, Ison MG, Danziger-Isakov L: Long-term infectious complications of kidney transplantation. Clin J Am Soc Nephrol 17: 286295, 2022 10.2215/CJN.15971020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2

    Cohen G: Immune dysfunction in uremia 2020. Toxins (Basel) 12: 439, 2020 10.3390/toxins12070439 PubMed

  • 3

    Espi M, Koppe L, Fouque D, Thaunat O: Chronic kidney disease-associated immune dysfunctions: Impact of protein-bound uremic retention solutes on immune cells. Toxins (Basel) 12: 300, 2020 10.3390/toxins12050300 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4

    Luo D, Zhao W, Lin Z, Wu J, Lin H, Li Y, et al.: The effects of hemodialysis and peritoneal dialysis on the gut microbiota of end-stage renal disease patients, and the relationship between gut microbiota and patient prognoses. Front Cell Infect Microbiol 11: 579386, 2021 10.3389/fcimb.2021.579386 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5

    Salvadori M, Tsalouchos A: Microbiota, renal disease and renal transplantation. World J Transplant 11: 1636, 2021 10.5500/wjt.v11.i3.16 PubMed

  • 6

    Kim JS, Sze C, Barbar T, Lee JR: New insights into the microbiome in kidney transplantation. Curr Opin Organ Transplant 26: 582586, 2021 10.1097/MOT.0000000000000921 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7

    Midturi JK, Ranganath S: Prevention and treatment of multidrug-resistant organisms in end-stage renal disease. Adv Chronic Kidney Dis 26: 5160, 2019 10.1053/j.ackd.2018.09.003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8

    Anesi JA, Blumberg EA, Han JH, Lee DH, Clauss H, Hasz R, et al.; CDC Prevention Epicenters Program: Impact of donor multidrug-resistant organisms on solid organ transplant recipient outcomes. Transpl Infect Dis 24: e13783, 2022 10.1111/tid.13783 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9

    So M, Hand J, Forrest G, Pouch SM, Te H, Ardura MI, et al.: White paper on antimicrobial stewardship in solid organ transplant recipients. Am J Transplant 22: 96112, 2022 10.1111/ajt.16743 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10

    Goldman JD, Julian K: Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33: e13507, 2019 10.1111/ctr.13507 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11

    Coussement J, Kamar N, Matignon M, Weekers L, Scemla A, Giral M, et al.; Bacteriuria in Renal Transplantation (BiRT) study group: Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): A pragmatic, multicentre, randomized, controlled trial. Clin Microbiol Infect 27: 398405, 2021 10.1016/j.cmi.2020.09.005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12

    Coussement J, Kaminski H, Scemla A, Manuel O: Asymptomatic bacteriuria and urinary tract infections in kidney transplant recipients. Curr Opin Infect Dis 33: 419425, 2020 10.1097/QCO.0000000000000678 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13

    Thompson ER, Hosgood SA, Nicholson ML, Wilson CH: Early versus late ureteric stent removal after kidney transplantation. Cochrane Database Syst Rev 1: CD011455, 2018 10.1002/14651858.CD011455.pub2 PubMed

    • Search Google Scholar
    • Export Citation
  • 14

    Wang Y, Yang Y, Zhang H, Wang Y: Early removal of ureteral stent after kidney transplant could decrease incidence of urinary tract infection: A systematic review and meta-analysis. Exp Clin Transplant 20: 2834, 2022 10.6002/ect.2021.0183 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15

    Lee JH, Muthukumar T, Kim J, Aull MJ, Watkins A, Kapur S, et al.: Antibiotic prophylaxis for ureteral stent removal after kidney transplantation. Clin Transplant 33: e13491, 2019 10.1111/ctr.13491 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16

    Chueng T, Suarez JF, Camargo JF: Efficacy and tolerability of fosfomycin in prevention of recurrent urinary tract infections among kidney transplant recipients. Transpl Infect Dis 21: e13042, 2019 10.1111/tid.13042 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17

    Arreola-Guerra JM, Rosado-Canto R, Alberú J, Maravilla E, Torres-González P, Criollo E, et al.: Fosfomycin trometamol in the prophylaxis of post-kidney transplant urinary tract infection: A controlled, randomized clinical trial. Transpl Infect Dis 20: e12980, 2018 10.1111/tid.12980 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18

    Rosado-Canto R, Parra-Avila I, Tejeda-Maldonado J, Kauffman-Ortega C, Rodriguez-Covarrubias FT, Trujeque-Matos M, et al.: Perioperative fosfomycin disodium prophylaxis against urinary tract infection in renal transplant recipients: a randomized clinical trial. Nephrol Dial Transplant 35: 19962003, 2020 10.1093/ndt/gfz261 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19

    Magruder M, Edusei E, Zhang L, Albakry S, Satlin MJ, Westblade LF, et al.: Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection. Gut Microbes 12: 1805281, 2020 10.1080/19490976.2020.1805281 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20

    Zgoura P, Waldecker C, Bauer F, Seibert FS, Rohn B, Schenker P, et al.: Vaccination against urinary tract infection after renal transplantation. Transplant Proc 52: 31923196, 2020 10.1016/j.transproceed.2020.06.018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21

    Tractenberg RE, Groah SL, Frost JK, Rounds AK, Davis E, Ljungberg IH, et al.: Effects of intravesical Lactobacillus Rhamnosus GG on urinary symptom burden in people with neurogenic lower urinary tract dysfunction. PM R 13: 695706, 2021 10.1002/pmrj.12470 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22

    Imlay H, Baum P, Brennan DC, Hanson KE, Hodges MR, Hodowanec AC, et al.; BK Disease Definitions Working Group of the Transplantation Associated Virus Infection Forum with the Forum for Collaborative Research: Consensus definitions of BK polyomavirus nephropathy in renal transplant recipients for clinical trials [published online ahead of print February 1, 2022]. Clin Infect Dis 10.1093/cid/ciac072 PubMed

    • Search Google Scholar
    • Export Citation
  • 23

    Chong S, Antoni M, Macdonald A, Reeves M, Harber M, Magee CN: BK virus: Current understanding of pathogenicity and clinical disease in transplantation. Rev Med Virol 29: e2044, 2019 10.1002/rmv.2044

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24

    Molnar MZ, Potluri VS, Schaubel DE, Sise ME, Concepcion BP, Forbes RC, et al.: Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. Am J Transplant 22: 599609, 2022 10.1111/ajt.16834 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25

    Velay A, Solis M, Benotmane I, Gantner P, Soulier E, Moulin B, et al.: Intravenous immunoglobulin administration significantly increases BKPyV genotype-specific neutralizing antibody titers in kidney transplant recipients. Antimicrob Agents Chemother 63: e00393-19, 2019 10.1128/AAC.00393-19 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26

    Kaur A, Wilhelm M, Wilk S, Hirsch HH: BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update. Curr Opin Infect Dis 32: 575583, 2019 10.1097/QCO.0000000000000602 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27

    Benotmane I, Solis M, Velay A, Cognard N, Olagne J, Gautier Vargas G, et al.: Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients-Results from a proof-of-concept study. Am J Transplant 21: 329337, 2021 10.1111/ajt.16233 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28

    Adekunle RO, Mehta AK, Wang Z, Patzer RE, Zhang R: Early steps to kidney transplantation among persons with HIV and end-stage renal disease in ESRD network 6. Transpl Infect Dis 24: e13767, 2022 10.1111/tid.13767 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29

    Sawinski D: Kidney transplantation in patients with HIV. Kidney360 1: 705711, 2020 10.34067/KID.0002112020 PubMed

  • 30

    Zheng X, Gong L, Xue W, Zeng S, Xu Y, Zhang Y, et al.: Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis. AIDS Res Ther 16: 37, 2019 10.1186/s12981-019-0253-z PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31

    Malat GE, Boyle SM, Jindal RM, Guy S, Xiao G, Harhay MN, et al.: Kidney transplantation in HIV-positive patients: A single-center, 16-year experience. Am J Kidney Dis 73: 112118, 2019 10.1053/j.ajkd.2018.02.352 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32

    Al-Adra D, Al-Qaoud T, Fowler K, Wong G: De novo malignancies after kidney transplantation. Clin J Am Soc Nephrol 17: 434443, 2022 10.2215/CJN.14570920

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33

    Cheung CY, Tang SCW: An update on cancer after kidney transplantation. Nephrol Dial Transplant 34: 914920, 2019 10.1093/ndt/gfy262 PubMed

  • 34

    Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, et al.; American Society of Transplantation: Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 11: S1S86, 2000 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35

    Thet Z, Lam AK, Ranganathan D, Aung SY, Han T, Khoo TK: Reducing non-melanoma skin cancer risk in renal transplant recipients. Nephrology (Carlton) 26: 907919, 2021 10.1111/nep.13939 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36

    Coghill AE, Johnson LG, Berg D, Resler AJ, Leca N, Madeleine MM: Immunosuppressive medications and squamous cell skin carcinoma: Nested case-control study within the Skin Cancer after Organ Transplant (SCOT) Cohort. Am J Transplant 16: 565573, 2016 10.1111/ajt.13596 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37

    Chen AC, Martin AJ, Choy B, Fernández-Peñas P, Dalziell RA, McKenzie CA, et al.: A Phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 373: 16181626, 2015 10.1056/NEJMoa1506197 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38

    Drago F, Ciccarese G, Cogorno L, Calvi C, Marsano LA, Parodi A: Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study. Eur J Dermatol 27: 382385, 2017 10.1684/ejd.2017.3025 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39

    Hadeler EK, Maderal AD: Drug interactions of natural supplements in dermatology: A review. Int J Dermatol 60: 11831189, 2021 10.1111/ijd.15389

    • Search Google Scholar
    • Export Citation
  • 40

    Ma MKM, Lim WH, Turner RM, Chapman JR, Craig JC, Wong G: The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: A registry analysis. Transplantation 98: 12861293, 2014 10.1097/TP.0000000000000375 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41

    Sprangers B, Riella LV, Dierickx D: Posttransplant lymphoproliferative disorder following kidney transplantation: A review. Am J Kidney Dis 78: 272281, 2021 10.1053/j.ajkd.2021.01.015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42

    Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, et al.; French PTLD Registry: A French cohort study of kidney retransplantation after post-transplant lymphoproliferative disorders. Clin J Am Soc Nephrol 12: 16631670, 2017 10.2215/CJN.03790417 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43

    Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, et al.: Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder. Clin Transplant 30: 6065, 2016 10.1111/ctr.12659 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44

    Leeaphorn N, Thongprayoon C, Chewcharat A, Hansrivijit P, Jadlowiec CC, Cummings LS, et al.: Outcomes of kidney retransplantation in recipients with prior posttransplant lymphoproliferative disorders: An analysis of the 2000-2019 UNOS/OPTN database. Am J Transplant 21: 846853, 2021 10.1111/ajt.16385 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45

    Abdel-Wahab N, Safa H, Abudayyeh A, Johnson DH, Trinh VA, Zobniw CM, et al.: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer 7: 106, 2019 10.1186/s40425-019-0585-1 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46

    Rossi E, Schinzari G, Maiorano BA, Esposito I, Acampora A, Romagnoli J, et al.: Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: a systematic review. Immunotherapy 14: 6575, 2022 10.2217/imt-2021-0195 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 47

    Ong SC, Mannon RB: Use of checkpoint inhibitors in a kidney transplant recipient with metastatic cancer. Clin J Am Soc Nephrol 15: 11901192, 2020 10.2215/CJN.15941219 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48

    Adam BA, Murakami N, Reid G, Du K, Jasim R, Boils CL, et al.: Gene expression profiling in kidney transplants with immune checkpoint inhibitor-associated adverse events. Clin J Am Soc Nephrol 16: 13761386, 2021 10.2215/CJN.00920121 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 49

    Khairallah P, Nickolas TL: Bone and mineral disease in kidney transplant recipients. Clin J Am Soc Nephrol 17: 121130, 2022 10.2215/CJN.03410321 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50

    Mathur A, Sutton W, Ahn JB, Prescott JD, Zeiger MA, Segev DL, et al.: Association between treatment of secondary hyperparathyroidism and posttransplant outcomes. Transplantation 105: e366e374, 2021 10.1097/TP.0000000000003653 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 51

    Sutton W, Chen X, Patel P, Karzai S, Prescott JD, Segev DL, et al.: Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients. Surgery 171: 6976, 2022 10.1016/j.surg.2021.03.067 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 52

    Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, Gómez-Vaquero C, et al.: A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol 27: 24872494, 2016 10.1681/ASN.2015060622 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 53

    Moreno P, Coloma A, Torregrosa JV, Montero N, Francos J, Codina S, et al.: Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism. Clin Transplant 34: e13988, 2020 10.1111/ctr.13988 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 54

    Brazier F, Jouffroy J, Martinez F, Nguyen-Khoa T, Anglicheau D, Legendre C, et al.: Association of blood bicarbonate and pH with mineral metabolism disturbance and outcome after kidney transplantation. Am J Transplant 20: 10631075, 2020 10.1111/ajt.15686 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 55

    Gojowy D, Skiba K, Bartmanska M, Kolonko A, Wiecek A, Adamczak M: Is metabolic acidosis a novel risk factor for a long-term graft survival in patients after kidney transplantation? Kidney Blood Press Res 45: 702712, 2020 10.1159/000508476 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 56

    Wiegand A, Ritter A, Graf N, Arampatzis S, Sidler D, Hadaya K, et al.: Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): Rationale and study protocol. BMC Nephrol 19: 177, 2018 10.1186/s12882-018-0956-8 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 57

    McMahon EJ, Campbell KL, Bauer JD, Mudge DW, Kelly JT: Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev 6: CD010070, 2021 10.1002/14651858.CD010070.pub3 PubMed

    • Search Google Scholar
    • Export Citation
  • 58

    Wagner S, Merkling T, Metzger M, Bankir L, Laville M, Frimat L, et al.; CKD-REIN study group: Water intake and progression of chronic kidney disease: The CKD-REIN cohort study. Nephrol Dial Transplant 37: 730739, 2022 10.1093/ndt/gfab036 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 59

    Ibrahim HN, Murad DN, Knoll GA: Thinking outside the box: Novel kidney protective strategies in kidney transplantation. Clin J Am Soc Nephrol 16: 18901897, 2021 10.2215/CJN.15070920 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 60

    Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, et al.: Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. Nephrol Dial Transplant 34: 760773, 2019 10.1093/ndt/gfz053 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 61

    Zoccali C, Roumeliotis S, Mallamaci F: Sleep apnea as a cardiorenal risk factor in CKD and renal transplant patients. Blood Purif 50: 642648, 2021 10.1159/000513424 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 62

    Mallamaci F, Tripepi R, D’Arrigo G, Panuccio V, Parlongo G, Caridi G, et al.: Sleep-disordered breathing and 24-hour ambulatory blood pressure monitoring in renal transplant patients: Longitudinal study. J Am Heart Assoc 9: e016237, 2020 10.1161/JAHA.120.016237 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 63

    Bangalore S, Maron DJ, O’Brien SM, Fleg JL, Kretov EI, Briguori C, et al.; ISCHEMIA-CKD Research Group: Management of coronary disease in patients with advanced kidney disease. N Engl J Med 382: 16081618, 2020 10.1056/NEJMoa1915925 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 64

    Herzog CA, Simegn MA, Xu Y, Costa SP, Mathew RO, El-Hajjar MC, et al.: Kidney transplant list status and outcomes in the ISCHEMIA-CKD Trial. J Am Coll Cardiol 78: 348361, 2021 10.1016/j.jacc.2021.05.001 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 65

    Nimmo A, Forsyth JL, Oniscu GC, Robb M, Watson C, Fotheringham J, et al.: A propensity score-matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipients. Kidney Int 99: 431442, 2021 10.1016/j.kint.2020.10.019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 66

    Ying T, Tran A, Webster AC, Klarenbach SW, Gill J, Chadban S, et al.: Screening for asymptomatic coronary artery disease in waitlisted kidney transplant candidates: A cost-utility analysis. Am J Kidney Dis 75: 693704, 2020 10.1053/j.ajkd.2019.10.001 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 67

    Ying T, Gill J, Webster A, Kim SJ, Morton R, Klarenbach SW, et al.: Canadian-Australasian randomised trial of screening kidney transplant candidates for coronary artery disease-A trial protocol for the CARSK study. Am Heart J 214: 175183, 2019 10.1016/j.ahj.2019.05.008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 68

    Siddiqui MU, Junarta J, Marhefka GD: Coronary revascularization versus optimal medical therapy in renal transplant candidates with coronary artery disease: A systematic review and meta-analysis. J Am Heart Assoc 11: e023548, 2022 10.1161/JAHA.121.023548 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 69

    Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, et al.: KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation 104: S11S103, 2020 10.1097/TP.0000000000003136. Available at: https://kdigo.org/wp-content/uploads/2018/08/KDIGO-Txp-Candidate-GL-FINAL.pdf. Accessed February 28, 2022

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 70

    Whelan AM, Ku E: Use of ambulatory blood pressure monitoring in kidney transplant recipients. Nephrol Dial Transplant 34: 14371439, 2019 10.1093/ndt/gfz010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 71

    Mallamaci F, Tripepi R, D’Arrigo G, Porto G, Versace MC, Marino C, et al.: Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study. Nephrol Dial Transplant 34: 15581564, 2019 10.1093/ndt/gfy355 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 72

    Korogiannou M, Sarafidis P, Theodorakopoulou MP, Alexandrou ME, Xagas E, Boletis IN, et al.: Diagnostic performance of office versus ambulatory blood pressure in kidney transplant recipients. Am J Nephrol 52: 548558, 2021 10.1159/000517358 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 73

    Korogiannou M, Sarafidis P, Theodorakopoulou MP, Alexandrou ME, Xagas E, Argyris A, et al.: Sex differences in ambulatory blood pressure levels, control, and phenotypes of hypertension in kidney transplant recipients. J Hypertens 40: 356363, 2022 10.1097/HJH.0000000000003019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 74

    Wadei HM, Amer H, Taler SJ, Cosio FG, Griffin MD, Grande JP, et al.: Diurnal blood pressure changes one year after kidney transplantation: Relationship to allograft function, histology, and resistive index. J Am Soc Nephrol 18: 16071615, 2007 10.1681/ASN.2006111289 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 75

    Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al.: Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int 99: 559569, 2021 10.1016/j.kint.2020.10.026 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 76

    Cross NB, Webster AC, Masson P, O’connell PJ, Craig JC: Antihypertensives for kidney transplant recipients: Systematic review and meta-analysis of randomized controlled trials. Transplantation 88: 718, 2009 10.1097/TP.0b013e3181a9e960 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 77

    Knoll GA, Fergusson D, Chassé M, Hebert P, Wells G, Tibbles LA, et al.: Ramipril versus placebo in kidney transplant patients with proteinuria: A multicentre, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol 4: 318326, 2016 10.1016/S2213-8587(15)00368-X PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 78

    Ibrahim HN, Jackson S, Connaire J, Matas A, Ney A, Najafian B, et al.: Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 24: 320327, 2013 10.1681/ASN.2012080777 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 79

    Philipp T, Martinez F, Geiger H, Moulin B, Mourad G, Schmieder R, et al.: Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant 25: 967976, 2010 10.1093/ndt/gfp581 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 80

    Hiremath S, Fergusson DA, Fergusson N, Bennett A, Knoll GA: Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: A meta-analysis of randomized controlled trials. Am J Kidney Dis 69: 7886, 2017 10.1053/j.ajkd.2016.08.018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 81

    Issa N, Ortiz F, Reule SA, Kukla A, Kasiske BL, Mauer M, et al.: The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure [published correction appears in Kidney Int 87: 243, 2015]. Kidney Int 85: 404415, 2014 10.1038/ki.2013.278 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 82

    Birdwell KA, Park M: Post-transplant cardiovascular disease. Clin J Am Soc Nephrol 16: 18781889, 2021 10.2215/CJN.00520121 PubMed

  • 83

    Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, et al.; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet 361: 20242031, 2003 10.1016/S0140-6736(03)13638-0 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 84

    Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, et al.; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study. Am J Transplant 5: 29292936, 2005 10.1111/j.1600-6143.2005.01105.x PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 85

    de Zeeuw D, Anzalone DA, Cain VA, Cressman MD, Heerspink HJ, Molitoris BA, et al.: Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): A randomised clinical trial. Lancet Diabetes Endocrinol 3: 181190, 2015 10.1016/S2213-8587(14)70246-3 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 86

    Papasotiriou M, Ntrinias T, Savvidaki E, Papachristou E, Goumenos DS: Treatment of mixed dyslipidemia with alirocumab in a kidney transplant recipient: A case report. Transplant Proc 53: 27752778, 2021 10.1016/j.transproceed.2021.08.027 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 87

    Chowdhury TA: Post-transplant diabetes mellitus. Clin Med (Lond) 19: 392395, 2019 10.7861/clinmed.2019-0195 PubMed

  • 88

    Li J, Chong A, Carey S: Dietary interventions on the prevention and management of diabetes in post-kidney transplantation - A systematic review. Nephrology (Carlton) 27: 269280, 2022 10.1111/nep.13982 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 89

    Wissing KM, Abramowicz D, Weekers L, Budde K, Rath T, Witzke O, et al.: Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation. Am J Transplant 18: 17261734, 2018 10.1111/ajt.14665 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 90

    Axelrod DA, Cheungpasitporn W, Bunnapradist S, Schnitzler MA, Xiao H, McAdams-DeMarco M, et al.: Posttransplant diabetes mellitus and immunosuppression selection in older and obese kidney recipients. Kidney Med 4: 100377, 2021 10.1016/j.xkme.2021.08.012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 91

    Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al.; DAPA-CKD Trial Committees and Investigators: Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383: 14361446, 2020 10.1056/NEJMoa2024816 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 92

    Kanbay M, Demiray A, Afsar B, Karakus KE, Ortiz A, Hornum M, et al.: Sodium-glucose cotransporter 2 inhibitors for diabetes mellitus control after kidney transplantation: Review of the current evidence. Nephrology (Carlton) 26: 10071017, 2021 10.1111/nep.13941 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 93

    AlKindi F, Al-Omary HL, Hussain Q, Al Hakim M, Chaaban A, Boobes Y: Outcomes of SGLT2 inhibitors use in diabetic renal transplant patients. Transplant Proc 52: 175178, 2020 10.1016/j.transproceed.2019.11.007 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 94

    Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, et al.: Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus. Diabetes Care 42: 10671074, 2019 10.2337/dc19-0093 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 95

    Shuster S, Al-Hadhrami Z, Moore S, Awad S, Shamseddin MK: Use of sodium-glucose cotransporter-2 inhibitors in renal transplant patients with diabetes: A brief review of the current literature. Can J Diabetes 46: 207212, 2022 10.1016/j.jcjd.2021.06.003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 96

    Ertuglu LA, Porrini E, Hornum M, Demiray A, Afsar B, Ortiz A, et al.: Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation. Transpl Int 34: 13411359, 2021 10.1111/tri.13883 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 97

    Hart A, Lentine KL, Smith JM, Miller JM, Skeans MA, Prentice M, et al.: OPTN/SRTR 2019 Annual Data Report: Kidney. Am J Transplant 21: 21137, 2021 10.1111/ajt.16502 PubMed. Available at: https://srtr.transplant.hrsa.gov/annual_reports/2019_ADR_Preview.aspx. Accessed January 25, 2022

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 98

    Veroux M, Mattone E, Cavallo M, Gioco R, Corona D, Volpicelli A, et al.: Obesity and bariatric surgery in kidney transplantation: A clinical review. World J Diabetes 12: 15631575, 2021 10.4239/wjd.v12.i9.1563 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 99

    Sureshkumar KK, Chopra B, Josephson MA, Shah PB, McGill RL: Recipient obesity and kidney transplant outcomes: A mate-kidney analysis. Am J Kidney Dis 78: 501510.e1, 2021 10.1053/j.ajkd.2021.02.332 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 100

    Cohen JB, Lim MA, Tewksbury CM, Torres-Landa S, Trofe-Clark J, Abt PL, et al.: Bariatric surgery before and after kidney transplantation: Long-term weight loss and allograft outcomes. Surg Obes Relat Dis 15: 935941, 2019 10.1016/j.soard.2019.04.002 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 101

    Ku E, McCulloch CE, Roll GR, Posselt A, Grimes BA, Johansen KL: Bariatric surgery prior to transplantation and risk of early hospital re-admission, graft failure, or death following kidney transplantation. Am J Transplant 21: 37503757, 2021 10.1111/ajt.16779 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 102

    Spaggiari M, Di Cocco P, Tulla K, Kaylan KB, Masrur MA, Hassan C, et al.: Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure. Am J Transplant 21: 15251534, 2021 10.1111/ajt.16322 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 103

    Anis KH, Weinrauch LA, D’Elia JA: Effects of smoking on solid organ transplantation outcomes. Am J Med 132: 413419, 2019 10.1016/j.amjmed.2018.11.005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 104

    Formanek P, Salisbury-Afshar E, Afshar M: Helping patients with ESRD and earlier stages of CKD to quit smoking. Am J Kidney Dis 72: 255266, 2018 10.1053/j.ajkd.2018.01.057 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 105

    Devresse A, Gohy S, Robert A, Kanaan N: How to manage cigarette smoking in kidney transplant candidates and recipients? Clin Kidney J 14: 22952303, 2021 10.1093/ckj/sfab072 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 106

    Walther CP, Nambi V, Hanania NA, Navaneethan SD: Diagnosis and management of pulmonary hypertension in patients with CKD. Am J Kidney Dis 75: 935945, 2020 10.1053/j.ajkd.2019.12.005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 107

    Lentine KL, Lam NN, Caliskan Y, Xiao H, Axelrod DA, Costa SP, et al.: Incidence, clinical correlates, and outcomes of pulmonary hypertension after kidney transplantation: Analysis of linked US registry and Medicare billing claims. Transplantation 106: 666675, 2022 10.1097/TP.0000000000003783 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 108

    Rao NN, Stokes MB, Rajwani A, Ullah S, Williams K, King D, et al.: Effects of arteriovenous fistula ligation on cardiac structure and function in kidney transplant recipients. Circulation 139: 28092818, 2019 10.1161/CIRCULATIONAHA.118.038505 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 109

    Lubetzky M, Tantisattamo E, Molnar MZ, Lentine KL, Basu A, Parsons RF, et al.: The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients. Am J Transplant 21: 29372949, 2021 10.1111/ajt.16717 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 110

    Uffing A, Hullekes F, Riella LV, Hogan JJ: Recurrent glomerular disease after kidney transplantation. Clin J Am Soc Nephrol 16: 17301742, 2021 10.2215/CJN.00280121 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 111

    Mannon RB: Acute kidney injury in kidney transplants: New insights. Nephron 143: 193196, 2019 10.1159/000500550 PubMed

  • 112

    Bahl D, Haddad Z, Datoo A, Qazi YA: Delayed graft function in kidney transplantation. Curr Opin Organ Transplant 24: 8286, 2019 10.1097/MOT.0000000000000604 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 113

    Metter C, Torrealba JR: Pathology of the kidney allograft. Semin Diagn Pathol 37: 148153, 2020 10.1053/j.semdp.2020.03.005 PubMed

  • 114

    Tantisattamo E, Hanna RM, Reddy UG, Ichii H, Dafoe DC, Danovitch GM, et al.: Novel options for failing allograft in kidney transplanted patients to avoid or defer dialysis therapy. Curr Opin Nephrol Hypertens 29: 8091, 2020 10.1097/MNH.0000000000000572 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 115

    Davis S, Mohan S: Managing patients with failing kidney allograft: Many questions remain. Clin J Am Soc Nephrol 17: 444451, 2022 10.2215/CJN.14620920 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 116

    Huml AM, Sehgal AR: Hemodialysis quality metrics in the first year following a failed kidney transplant. Am J Nephrol 50: 161167, 2019 10.1159/000501605 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 117

    Agrawal N, Pavlakis M: Caring for the patient with a failing allograft: Challenges and opportunities. Curr Opin Organ Transplant 24: 416423, 2019 10.1097/MOT.0000000000000655 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 118

    Arshad A, Jackson-Spence F, Sharif A: Development and evaluation of dedicated low clearance transplant clinics for patients with failing kidney transplants. J Ren Care 45: 5158, 2019 10.1111/jorc.12268 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 119

    United States Renal Data System: 2021 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Available at: https://adr.usrds.org/202 1. Accessed March 2, 2022

  • 120

    Schold JD, Augustine JJ, Huml AM, O’Toole J, Sedor JR, Poggio ED: Modest rates and wide variation in timely access to repeat kidney transplantation in the United States. Am J Transplant 20: 769778, 2020 10.1111/ajt.15646 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 121

    Kainz A, Kammer M, Reindl-Schwaighofer R, Strohmaier S, Petr V, Viklicky O, et al.: Waiting time for second kidney transplantation and mortality. Clin J Am Soc Nephrol 17: 9097, 2022 10.2215/CJN.07620621 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 122

    Alhamad T, Lubetzky M, Lentine KL, Edusei E, Parsons R, Pavlakis M, et al.: Kidney recipients with allograft failure, transition of kidney care (KRAFT): A survey of contemporary practices of transplant providers. Am J Transplant 21: 30343042, 2021 10.1111/ajt.16523 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 127 127 71
Full Text Views 201 201 179
PDF Downloads 280 280 252